Titre : Anticorps

Anticorps : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anticorps : Questions médicales les plus fréquentes", "headline": "Anticorps : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anticorps : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-30", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anticorps" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Immunoglobulines", "url": "https://questionsmedicales.fr/mesh/D007136", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines", "code": { "@type": "MedicalCode", "code": "D007136", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-idiotypiques", "alternateName": "Antibodies, Anti-Idiotypic", "url": "https://questionsmedicales.fr/mesh/D000888", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-idiotypiques", "code": { "@type": "MedicalCode", "code": "D000888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.071" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-archéens", "alternateName": "Antibodies, Archaeal", "url": "https://questionsmedicales.fr/mesh/D019844", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-archéens", "code": { "@type": "MedicalCode", "code": "D019844", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.107" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antibactériens", "alternateName": "Antibodies, Bacterial", "url": "https://questionsmedicales.fr/mesh/D000907", "about": { "@type": "MedicalCondition", "name": "Anticorps antibactériens", "code": { "@type": "MedicalCode", "code": "D000907", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.125" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antistreptolysine", "alternateName": "Antistreptolysin", "url": "https://questionsmedicales.fr/mesh/D000989", "about": { "@type": "MedicalCondition", "name": "Antistreptolysine", "code": { "@type": "MedicalCode", "code": "D000989", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.125.288" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps bispécifiques", "alternateName": "Antibodies, Bispecific", "url": "https://questionsmedicales.fr/mesh/D018033", "about": { "@type": "MedicalCondition", "name": "Anticorps bispécifiques", "code": { "@type": "MedicalCode", "code": "D018033", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.134" } } }, { "@type": "MedicalWebPage", "name": "Anticorps bloquants", "alternateName": "Antibodies, Blocking", "url": "https://questionsmedicales.fr/mesh/D019138", "about": { "@type": "MedicalCondition", "name": "Anticorps bloquants", "code": { "@type": "MedicalCode", "code": "D019138", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.143" } } }, { "@type": "MedicalWebPage", "name": "Anticorps catalytiques", "alternateName": "Antibodies, Catalytic", "url": "https://questionsmedicales.fr/mesh/D017151", "about": { "@type": "MedicalCondition", "name": "Anticorps catalytiques", "code": { "@type": "MedicalCode", "code": "D017151", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.167" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antifongiques", "alternateName": "Antibodies, Fungal", "url": "https://questionsmedicales.fr/mesh/D000908", "about": { "@type": "MedicalCondition", "name": "Anticorps antifongiques", "code": { "@type": "MedicalCode", "code": "D000908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.179" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antihelminthe", "alternateName": "Antibodies, Helminth", "url": "https://questionsmedicales.fr/mesh/D000909", "about": { "@type": "MedicalCondition", "name": "Anticorps antihelminthe", "code": { "@type": "MedicalCode", "code": "D000909", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.185" } } }, { "@type": "MedicalWebPage", "name": "Anticorps hétérophiles", "alternateName": "Antibodies, Heterophile", "url": "https://questionsmedicales.fr/mesh/D000910", "about": { "@type": "MedicalCondition", "name": "Anticorps hétérophiles", "code": { "@type": "MedicalCode", "code": "D000910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.191" } } }, { "@type": "MedicalWebPage", "name": "Anticorps monoclonaux", "alternateName": "Antibodies, Monoclonal", "url": "https://questionsmedicales.fr/mesh/D000911", "about": { "@type": "MedicalCondition", "name": "Anticorps monoclonaux", "code": { "@type": "MedicalCode", "code": "D000911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps monoclonaux humanisés", "alternateName": "Antibodies, Monoclonal, Humanized", "url": "https://questionsmedicales.fr/mesh/D061067", "about": { "@type": "MedicalCondition", "name": "Anticorps monoclonaux humanisés", "code": { "@type": "MedicalCode", "code": "D061067", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adalimumab", "alternateName": "Adalimumab", "url": "https://questionsmedicales.fr/mesh/D000068879", "about": { "@type": "MedicalCondition", "name": "Adalimumab", "code": { "@type": "MedicalCode", "code": "D000068879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.250" } } }, { "@type": "MedicalWebPage", "name": "Alemtuzumab", "alternateName": "Alemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000074323", "about": { "@type": "MedicalCondition", "name": "Alemtuzumab", "code": { "@type": "MedicalCode", "code": "D000074323", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.375" } } }, { "@type": "MedicalWebPage", "name": "Basiliximab", "alternateName": "Basiliximab", "url": "https://questionsmedicales.fr/mesh/D000077552", "about": { "@type": "MedicalCondition", "name": "Basiliximab", "code": { "@type": "MedicalCode", "code": "D000077552", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.407" } } }, { "@type": "MedicalWebPage", "name": "Bévacizumab", "alternateName": "Bevacizumab", "url": "https://questionsmedicales.fr/mesh/D000068258", "about": { "@type": "MedicalCondition", "name": "Bévacizumab", "code": { "@type": "MedicalCode", "code": "D000068258", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.438" } } }, { "@type": "MedicalWebPage", "name": "Brentuximab védotine", "alternateName": "Brentuximab Vedotin", "url": "https://questionsmedicales.fr/mesh/D000079963", "about": { "@type": "MedicalCondition", "name": "Brentuximab védotine", "code": { "@type": "MedicalCode", "code": "D000079963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.469" } } }, { "@type": "MedicalWebPage", "name": "Cétuximab", "alternateName": "Cetuximab", "url": "https://questionsmedicales.fr/mesh/D000068818", "about": { "@type": "MedicalCondition", "name": "Cétuximab", "code": { "@type": "MedicalCode", "code": "D000068818", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.750" } } }, { "@type": "MedicalWebPage", "name": "Daclizumab", "alternateName": "Daclizumab", "url": "https://questionsmedicales.fr/mesh/D000077561", "about": { "@type": "MedicalCondition", "name": "Daclizumab", "code": { "@type": "MedicalCode", "code": "D000077561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.766" } } }, { "@type": "MedicalWebPage", "name": "Dénosumab", "alternateName": "Denosumab", "url": "https://questionsmedicales.fr/mesh/D000069448", "about": { "@type": "MedicalCondition", "name": "Dénosumab", "code": { "@type": "MedicalCode", "code": "D000069448", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.782" } } }, { "@type": "MedicalWebPage", "name": "Gemtuzumab", "alternateName": "Gemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000079982", "about": { "@type": "MedicalCondition", "name": "Gemtuzumab", "code": { "@type": "MedicalCode", "code": "D000079982", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.790" } } }, { "@type": "MedicalWebPage", "name": "Inotuzumab ozogamicine", "alternateName": "Inotuzumab Ozogamicin", "url": "https://questionsmedicales.fr/mesh/D000080045", "about": { "@type": "MedicalCondition", "name": "Inotuzumab ozogamicine", "code": { "@type": "MedicalCode", "code": "D000080045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.794" } } }, { "@type": "MedicalWebPage", "name": "Ipilimumab", "alternateName": "Ipilimumab", "url": "https://questionsmedicales.fr/mesh/D000074324", "about": { "@type": "MedicalCondition", "name": "Ipilimumab", "code": { "@type": "MedicalCode", "code": "D000074324", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.798" } } }, { "@type": "MedicalWebPage", "name": "Natalizumab", "alternateName": "Natalizumab", "url": "https://questionsmedicales.fr/mesh/D000069442", "about": { "@type": "MedicalCondition", "name": "Natalizumab", "code": { "@type": "MedicalCode", "code": "D000069442", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.813" } } }, { "@type": "MedicalWebPage", "name": "Nivolumab", "alternateName": "Nivolumab", "url": "https://questionsmedicales.fr/mesh/D000077594", "about": { "@type": "MedicalCondition", "name": "Nivolumab", "code": { "@type": "MedicalCode", "code": "D000077594", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.829" } } }, { "@type": "MedicalWebPage", "name": "Omalizumab", "alternateName": "Omalizumab", "url": "https://questionsmedicales.fr/mesh/D000069444", "about": { "@type": "MedicalCondition", "name": "Omalizumab", "code": { "@type": "MedicalCode", "code": "D000069444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.844" } } }, { "@type": "MedicalWebPage", "name": "Palivizumab", "alternateName": "Palivizumab", "url": "https://questionsmedicales.fr/mesh/D000069455", "about": { "@type": "MedicalCondition", "name": "Palivizumab", "code": { "@type": "MedicalCode", "code": "D000069455", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.860" } } }, { "@type": "MedicalWebPage", "name": "Panitumumab", "alternateName": "Panitumumab", "url": "https://questionsmedicales.fr/mesh/D000077544", "about": { "@type": "MedicalCondition", "name": "Panitumumab", "code": { "@type": "MedicalCode", "code": "D000077544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.864" } } }, { "@type": "MedicalWebPage", "name": "Ranibizumab", "alternateName": "Ranibizumab", "url": "https://questionsmedicales.fr/mesh/D000069579", "about": { "@type": "MedicalCondition", "name": "Ranibizumab", "code": { "@type": "MedicalCode", "code": "D000069579", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.868" } } }, { "@type": "MedicalWebPage", "name": "Trastuzumab", "alternateName": "Trastuzumab", "url": "https://questionsmedicales.fr/mesh/D000068878", "about": { "@type": "MedicalCondition", "name": "Trastuzumab", "code": { "@type": "MedicalCode", "code": "D000068878", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } }, { "@type": "MedicalWebPage", "name": "Ustékinumab", "alternateName": "Ustekinumab", "url": "https://questionsmedicales.fr/mesh/D000069549", "about": { "@type": "MedicalCondition", "name": "Ustékinumab", "code": { "@type": "MedicalCode", "code": "D000069549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.937" } } } ] }, { "@type": "MedicalWebPage", "name": "Adalimumab", "alternateName": "Adalimumab", "url": "https://questionsmedicales.fr/mesh/D000068879", "about": { "@type": "MedicalCondition", "name": "Adalimumab", "code": { "@type": "MedicalCode", "code": "D000068879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.250" } } }, { "@type": "MedicalWebPage", "name": "Alemtuzumab", "alternateName": "Alemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000074323", "about": { "@type": "MedicalCondition", "name": "Alemtuzumab", "code": { "@type": "MedicalCode", "code": "D000074323", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.375" } } }, { "@type": "MedicalWebPage", "name": "Basiliximab", "alternateName": "Basiliximab", "url": "https://questionsmedicales.fr/mesh/D000077552", "about": { "@type": "MedicalCondition", "name": "Basiliximab", "code": { "@type": "MedicalCode", "code": "D000077552", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.407" } } }, { "@type": "MedicalWebPage", "name": "Bévacizumab", "alternateName": "Bevacizumab", "url": "https://questionsmedicales.fr/mesh/D000068258", "about": { "@type": "MedicalCondition", "name": "Bévacizumab", "code": { "@type": "MedicalCode", "code": "D000068258", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.438" } } }, { "@type": "MedicalWebPage", "name": "Brentuximab védotine", "alternateName": "Brentuximab Vedotin", "url": "https://questionsmedicales.fr/mesh/D000079963", "about": { "@type": "MedicalCondition", "name": "Brentuximab védotine", "code": { "@type": "MedicalCode", "code": "D000079963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.469" } } }, { "@type": "MedicalWebPage", "name": "Cétuximab", "alternateName": "Cetuximab", "url": "https://questionsmedicales.fr/mesh/D000068818", "about": { "@type": "MedicalCondition", "name": "Cétuximab", "code": { "@type": "MedicalCode", "code": "D000068818", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.750" } } }, { "@type": "MedicalWebPage", "name": "Daclizumab", "alternateName": "Daclizumab", "url": "https://questionsmedicales.fr/mesh/D000077561", "about": { "@type": "MedicalCondition", "name": "Daclizumab", "code": { "@type": "MedicalCode", "code": "D000077561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.766" } } }, { "@type": "MedicalWebPage", "name": "Dénosumab", "alternateName": "Denosumab", "url": "https://questionsmedicales.fr/mesh/D000069448", "about": { "@type": "MedicalCondition", "name": "Dénosumab", "code": { "@type": "MedicalCode", "code": "D000069448", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.782" } } }, { "@type": "MedicalWebPage", "name": "Gemtuzumab", "alternateName": "Gemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000079982", "about": { "@type": "MedicalCondition", "name": "Gemtuzumab", "code": { "@type": "MedicalCode", "code": "D000079982", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.790" } } }, { "@type": "MedicalWebPage", "name": "Inotuzumab ozogamicine", "alternateName": "Inotuzumab Ozogamicin", "url": "https://questionsmedicales.fr/mesh/D000080045", "about": { "@type": "MedicalCondition", "name": "Inotuzumab ozogamicine", "code": { "@type": "MedicalCode", "code": "D000080045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.794" } } }, { "@type": "MedicalWebPage", "name": "Ipilimumab", "alternateName": "Ipilimumab", "url": "https://questionsmedicales.fr/mesh/D000074324", "about": { "@type": "MedicalCondition", "name": "Ipilimumab", "code": { "@type": "MedicalCode", "code": "D000074324", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.798" } } }, { "@type": "MedicalWebPage", "name": "Natalizumab", "alternateName": "Natalizumab", "url": "https://questionsmedicales.fr/mesh/D000069442", "about": { "@type": "MedicalCondition", "name": "Natalizumab", "code": { "@type": "MedicalCode", "code": "D000069442", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.813" } } }, { "@type": "MedicalWebPage", "name": "Nivolumab", "alternateName": "Nivolumab", "url": "https://questionsmedicales.fr/mesh/D000077594", "about": { "@type": "MedicalCondition", "name": "Nivolumab", "code": { "@type": "MedicalCode", "code": "D000077594", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.829" } } }, { "@type": "MedicalWebPage", "name": "Omalizumab", "alternateName": "Omalizumab", "url": "https://questionsmedicales.fr/mesh/D000069444", "about": { "@type": "MedicalCondition", "name": "Omalizumab", "code": { "@type": "MedicalCode", "code": "D000069444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.844" } } }, { "@type": "MedicalWebPage", "name": "Palivizumab", "alternateName": "Palivizumab", "url": "https://questionsmedicales.fr/mesh/D000069455", "about": { "@type": "MedicalCondition", "name": "Palivizumab", "code": { "@type": "MedicalCode", "code": "D000069455", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.860" } } }, { "@type": "MedicalWebPage", "name": "Panitumumab", "alternateName": "Panitumumab", "url": "https://questionsmedicales.fr/mesh/D000077544", "about": { "@type": "MedicalCondition", "name": "Panitumumab", "code": { "@type": "MedicalCode", "code": "D000077544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.864" } } }, { "@type": "MedicalWebPage", "name": "Ranibizumab", "alternateName": "Ranibizumab", "url": "https://questionsmedicales.fr/mesh/D000069579", "about": { "@type": "MedicalCondition", "name": "Ranibizumab", "code": { "@type": "MedicalCode", "code": "D000069579", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.868" } } }, { "@type": "MedicalWebPage", "name": "Trastuzumab", "alternateName": "Trastuzumab", "url": "https://questionsmedicales.fr/mesh/D000068878", "about": { "@type": "MedicalCondition", "name": "Trastuzumab", "code": { "@type": "MedicalCode", "code": "D000068878", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } }, { "@type": "MedicalWebPage", "name": "Ustékinumab", "alternateName": "Ustekinumab", "url": "https://questionsmedicales.fr/mesh/D000069549", "about": { "@type": "MedicalCondition", "name": "Ustékinumab", "code": { "@type": "MedicalCode", "code": "D000069549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.937" } } }, { "@type": "MedicalWebPage", "name": "Anticorps monoclonaux d'origine murine", "alternateName": "Antibodies, Monoclonal, Murine-Derived", "url": "https://questionsmedicales.fr/mesh/D058846", "about": { "@type": "MedicalCondition", "name": "Anticorps monoclonaux d'origine murine", "code": { "@type": "MedicalCode", "code": "D058846", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.284" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Rituximab", "alternateName": "Rituximab", "url": "https://questionsmedicales.fr/mesh/D000069283", "about": { "@type": "MedicalCondition", "name": "Rituximab", "code": { "@type": "MedicalCode", "code": "D000069283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.284.785" } } } ] }, { "@type": "MedicalWebPage", "name": "Rituximab", "alternateName": "Rituximab", "url": "https://questionsmedicales.fr/mesh/D000069283", "about": { "@type": "MedicalCondition", "name": "Rituximab", "code": { "@type": "MedicalCode", "code": "D000069283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.284.785" } } }, { "@type": "MedicalWebPage", "name": "Infliximab", "alternateName": "Infliximab", "url": "https://questionsmedicales.fr/mesh/D000069285", "about": { "@type": "MedicalCondition", "name": "Infliximab", "code": { "@type": "MedicalCode", "code": "D000069285", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.642" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps antitumoraux", "alternateName": "Antibodies, Neoplasm", "url": "https://questionsmedicales.fr/mesh/D000912", "about": { "@type": "MedicalCondition", "name": "Anticorps antitumoraux", "code": { "@type": "MedicalCode", "code": "D000912", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.240" } } }, { "@type": "MedicalWebPage", "name": "Anticorps neutralisants", "alternateName": "Antibodies, Neutralizing", "url": "https://questionsmedicales.fr/mesh/D057134", "about": { "@type": "MedicalCondition", "name": "Anticorps neutralisants", "code": { "@type": "MedicalCode", "code": "D057134", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.244" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps neutralisants à large spectre", "alternateName": "Broadly Neutralizing Antibodies", "url": "https://questionsmedicales.fr/mesh/D000080908", "about": { "@type": "MedicalCondition", "name": "Anticorps neutralisants à large spectre", "code": { "@type": "MedicalCode", "code": "D000080908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.244.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps phospho-spécifiques", "alternateName": "Antibodies, Phospho-Specific", "url": "https://questionsmedicales.fr/mesh/D045163", "about": { "@type": "MedicalCondition", "name": "Anticorps phospho-spécifiques", "code": { "@type": "MedicalCode", "code": "D045163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.248" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiprotozoaires", "alternateName": "Antibodies, Protozoan", "url": "https://questionsmedicales.fr/mesh/D000913", "about": { "@type": "MedicalCondition", "name": "Anticorps antiprotozoaires", "code": { "@type": "MedicalCode", "code": "D000913", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.252" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiviraux", "alternateName": "Antibodies, Viral", "url": "https://questionsmedicales.fr/mesh/D000914", "about": { "@type": "MedicalCondition", "name": "Anticorps antiviraux", "code": { "@type": "MedicalCode", "code": "D000914", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps antideltarétrovirus", "alternateName": "Deltaretrovirus Antibodies", "url": "https://questionsmedicales.fr/mesh/D015480", "about": { "@type": "MedicalCondition", "name": "Anticorps antideltarétrovirus", "code": { "@type": "MedicalCode", "code": "D015480", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-VIH", "alternateName": "HIV Antibodies", "url": "https://questionsmedicales.fr/mesh/D015483", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-VIH", "code": { "@type": "MedicalCode", "code": "D015483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.440" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVI", "alternateName": "HTLV-I Antibodies", "url": "https://questionsmedicales.fr/mesh/D015481", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVI", "code": { "@type": "MedicalCode", "code": "D015481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.500" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVII", "alternateName": "HTLV-II Antibodies", "url": "https://questionsmedicales.fr/mesh/D015482", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVII", "code": { "@type": "MedicalCode", "code": "D015482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps anti-VIH", "alternateName": "HIV Antibodies", "url": "https://questionsmedicales.fr/mesh/D015483", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-VIH", "code": { "@type": "MedicalCode", "code": "D015483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.440" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVI", "alternateName": "HTLV-I Antibodies", "url": "https://questionsmedicales.fr/mesh/D015481", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVI", "code": { "@type": "MedicalCode", "code": "D015481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.500" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVII", "alternateName": "HTLV-II Antibodies", "url": "https://questionsmedicales.fr/mesh/D015482", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVII", "code": { "@type": "MedicalCode", "code": "D015482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.510" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite", "alternateName": "Hepatitis Antibodies", "url": "https://questionsmedicales.fr/mesh/D006508", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite", "code": { "@type": "MedicalCode", "code": "D006508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite A", "alternateName": "Hepatitis A Antibodies", "url": "https://questionsmedicales.fr/mesh/D035922", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite A", "code": { "@type": "MedicalCode", "code": "D035922", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.251" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite B", "alternateName": "Hepatitis B Antibodies", "url": "https://questionsmedicales.fr/mesh/D006510", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite B", "code": { "@type": "MedicalCode", "code": "D006510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.504" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite C", "alternateName": "Hepatitis C Antibodies", "url": "https://questionsmedicales.fr/mesh/D018937", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite C", "code": { "@type": "MedicalCode", "code": "D018937", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite A", "alternateName": "Hepatitis A Antibodies", "url": "https://questionsmedicales.fr/mesh/D035922", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite A", "code": { "@type": "MedicalCode", "code": "D035922", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.251" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite B", "alternateName": "Hepatitis B Antibodies", "url": "https://questionsmedicales.fr/mesh/D006510", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite B", "code": { "@type": "MedicalCode", "code": "D006510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.504" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite C", "alternateName": "Hepatitis C Antibodies", "url": "https://questionsmedicales.fr/mesh/D018937", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite C", "code": { "@type": "MedicalCode", "code": "D018937", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Autoanticorps", "alternateName": "Autoantibodies", "url": "https://questionsmedicales.fr/mesh/D001323", "about": { "@type": "MedicalCondition", "name": "Autoanticorps", "code": { "@type": "MedicalCode", "code": "D001323", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-protéines citrullinées", "alternateName": "Anti-Citrullinated Protein Antibodies", "url": "https://questionsmedicales.fr/mesh/D000075422", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-protéines citrullinées", "code": { "@type": "MedicalCode", "code": "D000075422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.095" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antinucléaires", "alternateName": "Antibodies, Antinuclear", "url": "https://questionsmedicales.fr/mesh/D000974", "about": { "@type": "MedicalCondition", "name": "Anticorps antinucléaires", "code": { "@type": "MedicalCode", "code": "D000974", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.204" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiphospholipides", "alternateName": "Antibodies, Antiphospholipid", "url": "https://questionsmedicales.fr/mesh/D017152", "about": { "@type": "MedicalCondition", "name": "Anticorps antiphospholipides", "code": { "@type": "MedicalCode", "code": "D017152", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anticardiolipines", "alternateName": "Antibodies, Anticardiolipin", "url": "https://questionsmedicales.fr/mesh/D017153", "about": { "@type": "MedicalCondition", "name": "Anticorps anticardiolipines", "code": { "@type": "MedicalCode", "code": "D017153", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps anticardiolipines", "alternateName": "Antibodies, Anticardiolipin", "url": "https://questionsmedicales.fr/mesh/D017153", "about": { "@type": "MedicalCondition", "name": "Anticorps anticardiolipines", "code": { "@type": "MedicalCode", "code": "D017153", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210.100" } } }, { "@type": "MedicalWebPage", "name": "Facteur néphritique C3", "alternateName": "Complement C3 Nephritic Factor", "url": "https://questionsmedicales.fr/mesh/D003178", "about": { "@type": "MedicalCondition", "name": "Facteur néphritique C3", "code": { "@type": "MedicalCode", "code": "D003178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.300" } } }, { "@type": "MedicalWebPage", "name": "Immunoconglutinines", "alternateName": "Immunoconglutinins", "url": "https://questionsmedicales.fr/mesh/D037561", "about": { "@type": "MedicalCondition", "name": "Immunoconglutinines", "code": { "@type": "MedicalCode", "code": "D037561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.390" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobulines thyréostimulantes", "alternateName": "Immunoglobulins, Thyroid-Stimulating", "url": "https://questionsmedicales.fr/mesh/D018828", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines thyréostimulantes", "code": { "@type": "MedicalCode", "code": "D018828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.480" } } }, { "@type": "MedicalWebPage", "name": "Facteur rhumatoïde", "alternateName": "Rheumatoid Factor", "url": "https://questionsmedicales.fr/mesh/D012217", "about": { "@type": "MedicalCondition", "name": "Facteur rhumatoïde", "code": { "@type": "MedicalCode", "code": "D012217", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.732" } } } ] }, { "@type": "MedicalWebPage", "name": "Abatacept", "alternateName": "Abatacept", "url": "https://questionsmedicales.fr/mesh/D000069594", "about": { "@type": "MedicalCondition", "name": "Abatacept", "code": { "@type": "MedicalCode", "code": "D000069594", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.580.225" } } }, { "@type": "MedicalWebPage", "name": "Isotypes des immunoglobulines", "alternateName": "Immunoglobulin Isotypes", "url": "https://questionsmedicales.fr/mesh/D007132", "about": { "@type": "MedicalCondition", "name": "Isotypes des immunoglobulines", "code": { "@type": "MedicalCode", "code": "D007132", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Immunoglobuline A", "alternateName": "Immunoglobulin A", "url": "https://questionsmedicales.fr/mesh/D007070", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A", "code": { "@type": "MedicalCode", "code": "D007070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Immunoglobuline A sécrétoire", "alternateName": "Immunoglobulin A, Secretory", "url": "https://questionsmedicales.fr/mesh/D007071", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A sécrétoire", "code": { "@type": "MedicalCode", "code": "D007071", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026.030" } } } ] }, { "@type": "MedicalWebPage", "name": "Immunoglobuline A sécrétoire", "alternateName": "Immunoglobulin A, Secretory", "url": "https://questionsmedicales.fr/mesh/D007071", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A sécrétoire", "code": { "@type": "MedicalCode", "code": "D007071", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026.030" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline D", "alternateName": "Immunoglobulin D", "url": "https://questionsmedicales.fr/mesh/D007072", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline D", "code": { "@type": "MedicalCode", "code": "D007072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.251" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline E", "alternateName": "Immunoglobulin E", "url": "https://questionsmedicales.fr/mesh/D007073", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline E", "code": { "@type": "MedicalCode", "code": "D007073", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.312" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline G", "alternateName": "Immunoglobulin G", "url": "https://questionsmedicales.fr/mesh/D007074", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline G", "code": { "@type": "MedicalCode", "code": "D007074", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "LATS", "alternateName": "Long-Acting Thyroid Stimulator", "url": "https://questionsmedicales.fr/mesh/D008135", "about": { "@type": "MedicalCondition", "name": "LATS", "code": { "@type": "MedicalCode", "code": "D008135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.550" } } }, { "@type": "MedicalWebPage", "name": "Muromonab-CD3", "alternateName": "Muromonab-CD3", "url": "https://questionsmedicales.fr/mesh/D016853", "about": { "@type": "MedicalCondition", "name": "Muromonab-CD3", "code": { "@type": "MedicalCode", "code": "D016853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.570" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline Rh", "alternateName": "Rho(D) Immune Globulin", "url": "https://questionsmedicales.fr/mesh/D018029", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline Rh", "code": { "@type": "MedicalCode", "code": "D018029", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.700" } } } ] }, { "@type": "MedicalWebPage", "name": "LATS", "alternateName": "Long-Acting Thyroid Stimulator", "url": "https://questionsmedicales.fr/mesh/D008135", "about": { "@type": "MedicalCondition", "name": "LATS", "code": { "@type": "MedicalCode", "code": "D008135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.550" } } }, { "@type": "MedicalWebPage", "name": "Muromonab-CD3", "alternateName": "Muromonab-CD3", "url": "https://questionsmedicales.fr/mesh/D016853", "about": { "@type": "MedicalCondition", "name": "Muromonab-CD3", "code": { "@type": "MedicalCode", "code": "D016853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.570" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline Rh", "alternateName": "Rho(D) Immune Globulin", "url": "https://questionsmedicales.fr/mesh/D018029", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline Rh", "code": { "@type": "MedicalCode", "code": "D018029", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.700" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline M", "alternateName": "Immunoglobulin M", "url": "https://questionsmedicales.fr/mesh/D007075", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline M", "code": { "@type": "MedicalCode", "code": "D007075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.574" } } } ] }, { "@type": "MedicalWebPage", "name": "Immunoglobulines par voie veineuse", "alternateName": "Immunoglobulins, Intravenous", "url": "https://questionsmedicales.fr/mesh/D016756", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines par voie veineuse", "code": { "@type": "MedicalCode", "code": "D016756", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.632" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-insuline", "alternateName": "Insulin Antibodies", "url": "https://questionsmedicales.fr/mesh/D007330", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-insuline", "code": { "@type": "MedicalCode", "code": "D007330", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.656" } } }, { "@type": "MedicalWebPage", "name": "Alloanticorps", "alternateName": "Isoantibodies", "url": "https://questionsmedicales.fr/mesh/D007518", "about": { "@type": "MedicalCondition", "name": "Alloanticorps", "code": { "@type": "MedicalCode", "code": "D007518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.664" } } }, { "@type": "MedicalWebPage", "name": "Planticorps", "alternateName": "Plantibodies", "url": "https://questionsmedicales.fr/mesh/D046549", "about": { "@type": "MedicalCondition", "name": "Planticorps", "code": { "@type": "MedicalCode", "code": "D046549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.820" } } }, { "@type": "MedicalWebPage", "name": "Précipitines", "alternateName": "Precipitins", "url": "https://questionsmedicales.fr/mesh/D011234", "about": { "@type": "MedicalCondition", "name": "Précipitines", "code": { "@type": "MedicalCode", "code": "D011234", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.837" } } }, { "@type": "MedicalWebPage", "name": "Réagines", "alternateName": "Reagins", "url": "https://questionsmedicales.fr/mesh/D011935", "about": { "@type": "MedicalCondition", "name": "Réagines", "code": { "@type": "MedicalCode", "code": "D011935", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.890" } } } ], "about": { "@type": "MedicalCondition", "name": "Anticorps", "alternateName": "Antibodies", "code": { "@type": "MedicalCode", "code": "D000906", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anita Bandrowski", "url": "https://questionsmedicales.fr/author/Anita%20Bandrowski", "affiliation": { "@type": "Organization", "name": "Center for Research in Biological Systems, University of California , La Jolla, CA, USA." } }, { "@type": "Person", "name": "Sophana Chea", "url": "https://questionsmedicales.fr/author/Sophana%20Chea", "affiliation": { "@type": "Organization", "name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia." } }, { "@type": "Person", "name": "Laura Willen", "url": "https://questionsmedicales.fr/author/Laura%20Willen", "affiliation": { "@type": "Organization", "name": "Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States." } }, { "@type": "Person", "name": "Sreynik Nhek", "url": "https://questionsmedicales.fr/author/Sreynik%20Nhek", "affiliation": { "@type": "Organization", "name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia." } }, { "@type": "Person", "name": "Piseth Ly", "url": "https://questionsmedicales.fr/author/Piseth%20Ly", "affiliation": { "@type": "Organization", "name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Intentional Rounding versus Standard of Care for Patients Hospitalised in Internal Medicine Wards: Results from a Cluster-Randomised Nation-Based Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35887739", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/jcm11143976" } }, { "@type": "ScholarlyArticle", "name": "Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature.", "datePublished": "2022-06-16", "url": "https://questionsmedicales.fr/article/35710306", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/annrheumdis-2022-222656" } }, { "@type": "ScholarlyArticle", "name": "Integrating a Group-Based, Early Childhood Parenting Intervention Into Primary Health Care Services in Rural Bangladesh: A Cluster-Randomized Controlled Trial.", "datePublished": "2022-06-10", "url": "https://questionsmedicales.fr/article/35783319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fped.2022.886542" } }, { "@type": "ScholarlyArticle", "name": "A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer.", "datePublished": "2022-05-25", "url": "https://questionsmedicales.fr/article/35613045", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/PAS.0000000000001920" } }, { "@type": "ScholarlyArticle", "name": "Anxiety sensitivity in relation to post-traumatic stress disorder symptom clusters among young adults with probable post-traumatic stress disorder.", "datePublished": "2022-05-13", "url": "https://questionsmedicales.fr/article/35549620", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/16506073.2022.2070539" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Globulines", "item": "https://questionsmedicales.fr/mesh/D005916" }, { "@type": "ListItem", "position": 5, "name": "Sérum-globulines", "item": "https://questionsmedicales.fr/mesh/D012712" }, { "@type": "ListItem", "position": 6, "name": "Immunoglobulines", "item": "https://questionsmedicales.fr/mesh/D007136" }, { "@type": "ListItem", "position": 7, "name": "Anticorps", "item": "https://questionsmedicales.fr/mesh/D000906" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anticorps - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anticorps", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anticorps", "description": "Comment détecte-t-on les anticorps dans le sang ?\nQuels tests sont utilisés pour les anticorps spécifiques ?\nLes anticorps peuvent-ils indiquer une infection ?\nQu'est-ce qu'un titre d'anticorps ?\nLes anticorps peuvent-ils être détectés chez les nouveau-nés ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Cluster+Analysis&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anticorps", "description": "Quels symptômes indiquent une réponse immunitaire ?\nLes anticorps causent-ils des symptômes ?\nComment les anticorps affectent-ils les allergies ?\nLes anticorps peuvent-ils causer des maladies auto-immunes ?\nQuels anticorps sont liés aux infections virales ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Cluster+Analysis&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anticorps", "description": "Comment les vaccins stimulent-ils la production d'anticorps ?\nLes anticorps peuvent-ils être transférés par le lait maternel ?\nComment maintenir un système immunitaire fort ?\nLes anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?\nLes anticorps sont-ils efficaces contre toutes les infections ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Cluster+Analysis&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anticorps", "description": "Comment les anticorps sont-ils utilisés en thérapie ?\nLes anticorps peuvent-ils être administrés par injection ?\nQu'est-ce que l'immunothérapie par anticorps ?\nLes anticorps peuvent-ils être utilisés pour prévenir des maladies ?\nQuels sont les effets secondaires des traitements par anticorps ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Cluster+Analysis&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anticorps", "description": "Quels sont les risques d'une surproduction d'anticorps ?\nLes anticorps peuvent-ils causer des réactions allergiques ?\nQuelles complications peuvent survenir avec des anticorps monoclonaux ?\nLes anticorps peuvent-ils interférer avec d'autres traitements ?\nQuelles sont les complications des maladies auto-immunes ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Cluster+Analysis&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anticorps", "description": "Quels facteurs augmentent le risque de maladies auto-immunes ?\nLe stress influence-t-il la production d'anticorps ?\nL'âge influence-t-il la réponse des anticorps ?\nLes infections antérieures affectent-elles la production d'anticorps ?\nLes habitudes alimentaires influencent-elles les anticorps ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Cluster+Analysis&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les anticorps dans le sang ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "On utilise des tests sérologiques comme l'ELISA pour mesurer les anticorps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les anticorps spécifiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'immunofluorescence ou les tests d'agglutination sont utilisés." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils indiquer une infection ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la présence d'anticorps spécifiques peut indiquer une infection antérieure." } }, { "@type": "Question", "name": "Qu'est-ce qu'un titre d'anticorps ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "C'est une mesure de la concentration d'anticorps dans le sang, indiquant l'immunité." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être détectés chez les nouveau-nés ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticorps maternels peuvent être détectés chez les nouveau-nés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réponse immunitaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, et inflammation peuvent indiquer une réponse immunitaire active." } }, { "@type": "Question", "name": "Les anticorps causent-ils des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, ce sont les maladies ou infections que les anticorps combattent qui causent des symptômes." } }, { "@type": "Question", "name": "Comment les anticorps affectent-ils les allergies ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les anticorps IgE sont impliqués dans les réactions allergiques, provoquant des symptômes." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils causer des maladies auto-immunes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anticorps peuvent attaquer les tissus sains, entraînant des maladies auto-immunes." } }, { "@type": "Question", "name": "Quels anticorps sont liés aux infections virales ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les anticorps IgM et IgG sont souvent associés aux infections virales." } }, { "@type": "Question", "name": "Comment les vaccins stimulent-ils la production d'anticorps ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins introduisent des antigènes, entraînant la production d'anticorps spécifiques." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être transférés par le lait maternel ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticorps maternels sont transférés au bébé par le lait maternel, offrant une protection." } }, { "@type": "Question", "name": "Comment maintenir un système immunitaire fort ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice et le sommeil aident à maintenir un système immunitaire fort." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements par anticorps monoclonaux sont utilisés pour prévenir les formes graves du COVID-19." } }, { "@type": "Question", "name": "Les anticorps sont-ils efficaces contre toutes les infections ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité dépend du type d'infection et de la réponse immunitaire individuelle." } }, { "@type": "Question", "name": "Comment les anticorps sont-ils utilisés en thérapie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des anticorps monoclonaux sont utilisés pour traiter diverses maladies, y compris le cancer." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être administrés par injection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticorps peuvent être administrés par injection pour traiter certaines maladies." } }, { "@type": "Question", "name": "Qu'est-ce que l'immunothérapie par anticorps ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est un traitement qui utilise des anticorps pour renforcer la réponse immunitaire contre le cancer." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être utilisés pour prévenir des maladies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anticorps spécifiques peuvent être administrés pour prévenir certaines infections." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements par anticorps ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des réactions allergiques et des infections." } }, { "@type": "Question", "name": "Quels sont les risques d'une surproduction d'anticorps ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner des maladies auto-immunes ou des allergies graves." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils causer des réactions allergiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anticorps peuvent provoquer des réactions allergiques en réponse à des allergènes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anticorps monoclonaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des infections, des réactions allergiques et des effets secondaires peuvent survenir." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils interférer avec d'autres traitements ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anticorps peuvent interagir avec d'autres médicaments, affectant leur efficacité." } }, { "@type": "Question", "name": "Quelles sont les complications des maladies auto-immunes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des dommages aux organes, des infections et une qualité de vie réduite." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de maladies auto-immunes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs génétiques, environnementaux et hormonaux peuvent augmenter ce risque." } }, { "@type": "Question", "name": "Le stress influence-t-il la production d'anticorps ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la réponse immunitaire et la production d'anticorps." } }, { "@type": "Question", "name": "L'âge influence-t-il la réponse des anticorps ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la réponse des anticorps peut diminuer avec l'âge, rendant les personnes âgées plus vulnérables." } }, { "@type": "Question", "name": "Les infections antérieures affectent-elles la production d'anticorps ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections antérieures peuvent influencer la mémoire immunitaire et la production d'anticorps." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les anticorps ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments peut soutenir la production d'anticorps et la santé immunitaire." } } ] } ] }

Sous-catégories

75 au total
└─

Anticorps anti-idiotypiques

Antibodies, Anti-Idiotypic D000888 - D12.776.377.715.548.114.071
└─

Anticorps anti-archéens

Antibodies, Archaeal D019844 - D12.776.377.715.548.114.107
└─

Anticorps antibactériens

Antibodies, Bacterial D000907 - D12.776.377.715.548.114.125
└─

Anticorps bispécifiques

Antibodies, Bispecific D018033 - D12.776.377.715.548.114.134
└─

Anticorps bloquants

Antibodies, Blocking D019138 - D12.776.377.715.548.114.143
└─

Anticorps catalytiques

Antibodies, Catalytic D017151 - D12.776.377.715.548.114.167
└─

Anticorps antifongiques

Antibodies, Fungal D000908 - D12.776.377.715.548.114.179
└─

Anticorps antihelminthe

Antibodies, Helminth D000909 - D12.776.377.715.548.114.185
└─

Anticorps hétérophiles

Antibodies, Heterophile D000910 - D12.776.377.715.548.114.191
└─

Anticorps monoclonaux

Antibodies, Monoclonal D000911 - D12.776.377.715.548.114.224
└─

Anticorps antitumoraux

Antibodies, Neoplasm D000912 - D12.776.377.715.548.114.240
└─

Anticorps neutralisants

Antibodies, Neutralizing D057134 - D12.776.377.715.548.114.244
└─

Anticorps phospho-spécifiques

Antibodies, Phospho-Specific D045163 - D12.776.377.715.548.114.248
└─

Anticorps antiprotozoaires

Antibodies, Protozoan D000913 - D12.776.377.715.548.114.252
└─

Anticorps antiviraux

Antibodies, Viral D000914 - D12.776.377.715.548.114.254
└─

Autoanticorps

Autoantibodies D001323 - D12.776.377.715.548.114.323
└─

Isotypes des immunoglobulines

Immunoglobulin Isotypes D007132 - D12.776.377.715.548.114.619
└─

Immunoglobulines par voie veineuse

Immunoglobulins, Intravenous D016756 - D12.776.377.715.548.114.632
└─

Anticorps anti-insuline

Insulin Antibodies D007330 - D12.776.377.715.548.114.656
└─

Alloanticorps

Isoantibodies D007518 - D12.776.377.715.548.114.664
└─

Planticorps

Plantibodies D046549 - D12.776.377.715.548.114.820
└─

Précipitines

Precipitins D011234 - D12.776.377.715.548.114.837
└─

Réagines

Reagins D011935 - D12.776.377.715.548.114.890
└─└─

Antistreptolysine

Antistreptolysin D000989 - D12.776.377.715.548.114.125.288
└─└─

Anticorps monoclonaux humanisés

Antibodies, Monoclonal, Humanized D061067 - D12.776.377.715.548.114.224.200
└─└─

Anticorps monoclonaux d'origine murine

Antibodies, Monoclonal, Murine-Derived D058846 - D12.776.377.715.548.114.224.284
└─└─

Infliximab

Infliximab D000069285 - D12.776.377.715.548.114.224.642
└─└─

Anticorps neutralisants à large spectre

Broadly Neutralizing Antibodies D000080908 - D12.776.377.715.548.114.244.500
└─└─

Anticorps antideltarétrovirus

Deltaretrovirus Antibodies D015480 - D12.776.377.715.548.114.254.150
└─└─

Anticorps de l'hépatite

Hepatitis Antibodies D006508 - D12.776.377.715.548.114.254.450
└─└─

Anticorps anti-protéines citrullinées

Anti-Citrullinated Protein Antibodies D000075422 - D12.776.377.715.548.114.323.095
└─└─

Anticorps antinucléaires

Antibodies, Antinuclear D000974 - D12.776.377.715.548.114.323.204
└─└─

Anticorps antiphospholipides

Antibodies, Antiphospholipid D017152 - D12.776.377.715.548.114.323.210
└─└─

Facteur néphritique C3

Complement C3 Nephritic Factor D003178 - D12.776.377.715.548.114.323.300
└─└─

Immunoconglutinines

Immunoconglutinins D037561 - D12.776.377.715.548.114.323.390
└─└─

Immunoglobulines thyréostimulantes

Immunoglobulins, Thyroid-Stimulating D018828 - D12.776.377.715.548.114.323.480
└─└─

Facteur rhumatoïde

Rheumatoid Factor D012217 - D12.776.377.715.548.114.323.732
└─└─

Abatacept

Abatacept D000069594 - D12.776.377.715.548.114.580.225
└─└─

Immunoglobuline A

Immunoglobulin A D007070 - D12.776.377.715.548.114.619.026
└─└─

Immunoglobuline D

Immunoglobulin D D007072 - D12.776.377.715.548.114.619.251
└─└─

Immunoglobuline E

Immunoglobulin E D007073 - D12.776.377.715.548.114.619.312
└─└─

Immunoglobuline G

Immunoglobulin G D007074 - D12.776.377.715.548.114.619.393
└─└─

Immunoglobuline M

Immunoglobulin M D007075 - D12.776.377.715.548.114.619.574
└─└─└─

Adalimumab

Adalimumab D000068879 - D12.776.377.715.548.114.224.200.250
└─└─└─

Alemtuzumab

Alemtuzumab D000074323 - D12.776.377.715.548.114.224.200.375
└─└─└─

Basiliximab

Basiliximab D000077552 - D12.776.377.715.548.114.224.200.407
└─└─└─

Bévacizumab

Bevacizumab D000068258 - D12.776.377.715.548.114.224.200.438
└─└─└─

Brentuximab védotine

Brentuximab Vedotin D000079963 - D12.776.377.715.548.114.224.200.469
└─└─└─

Cétuximab

Cetuximab D000068818 - D12.776.377.715.548.114.224.200.750
└─└─└─

Daclizumab

Daclizumab D000077561 - D12.776.377.715.548.114.224.200.766
└─└─└─

Dénosumab

Denosumab D000069448 - D12.776.377.715.548.114.224.200.782
└─└─└─

Gemtuzumab

Gemtuzumab D000079982 - D12.776.377.715.548.114.224.200.790
└─└─└─

Inotuzumab ozogamicine

Inotuzumab Ozogamicin D000080045 - D12.776.377.715.548.114.224.200.794
└─└─└─

Ipilimumab

Ipilimumab D000074324 - D12.776.377.715.548.114.224.200.798
└─└─└─

Natalizumab

Natalizumab D000069442 - D12.776.377.715.548.114.224.200.813
└─└─└─

Nivolumab

Nivolumab D000077594 - D12.776.377.715.548.114.224.200.829
└─└─└─

Omalizumab

Omalizumab D000069444 - D12.776.377.715.548.114.224.200.844
└─└─└─

Palivizumab

Palivizumab D000069455 - D12.776.377.715.548.114.224.200.860
└─└─└─

Panitumumab

Panitumumab D000077544 - D12.776.377.715.548.114.224.200.864
└─└─└─

Ranibizumab

Ranibizumab D000069579 - D12.776.377.715.548.114.224.200.868
└─└─└─

Trastuzumab

Trastuzumab D000068878 - D12.776.377.715.548.114.224.200.875
└─└─└─

Ustékinumab

Ustekinumab D000069549 - D12.776.377.715.548.114.224.200.937
└─└─└─

Rituximab

Rituximab D000069283 - D12.776.377.715.548.114.224.284.785
└─└─└─

Anticorps anti-VIH

HIV Antibodies D015483 - D12.776.377.715.548.114.254.150.440
└─└─└─

Anticorps anti-HTLVI

HTLV-I Antibodies D015481 - D12.776.377.715.548.114.254.150.500
└─└─└─

Anticorps anti-HTLVII

HTLV-II Antibodies D015482 - D12.776.377.715.548.114.254.150.510
└─└─└─

Anticorps de l'hépatite A

Hepatitis A Antibodies D035922 - D12.776.377.715.548.114.254.450.251
└─└─└─

Anticorps de l'hépatite B

Hepatitis B Antibodies D006510 - D12.776.377.715.548.114.254.450.504
└─└─└─

Anticorps de l'hépatite C

Hepatitis C Antibodies D018937 - D12.776.377.715.548.114.254.450.510
└─└─└─

Anticorps anticardiolipines

Antibodies, Anticardiolipin D017153 - D12.776.377.715.548.114.323.210.100
└─└─└─

Immunoglobuline A sécrétoire

Immunoglobulin A, Secretory D007071 - D12.776.377.715.548.114.619.026.030
└─└─└─

LATS

Long-Acting Thyroid Stimulator D008135 - D12.776.377.715.548.114.619.393.550
└─└─└─

Muromonab-CD3

Muromonab-CD3 D016853 - D12.776.377.715.548.114.619.393.570
└─└─└─

Immunoglobuline Rh

Rho(D) Immune Globulin D018029 - D12.776.377.715.548.114.619.393.700
└─└─└─└─

Ado-trastuzumab emtansine

Ado-Trastuzumab Emtansine D000080044 - D12.776.377.715.548.114.224.200.875.500

Sources (10000 au total)

Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature.

Lupus T cells demonstrate aberrant DNA methylation patterns dominated by hypomethylation of interferon-regulated genes. The objective of this study was to identify additional lupus-associated DNA meth... Genome-wide DNA methylation was assessed in naïve CD4... In addition to the previously reported epigenetic signature in interferon-regulated genes, we observed hypomethylation in the promoter region of the miR-17-92 cluster in patients with lupus. Members o... The lupus defining epigenetic signature, characterised by robust hypomethylation of interferon-regulated genes, does not appear to be determined by genetic factors. Hypomethylation of the miR-17-92 cl...

Integrating a Group-Based, Early Childhood Parenting Intervention Into Primary Health Care Services in Rural Bangladesh: A Cluster-Randomized Controlled Trial.

Over 250 million children globally do not reach their developmental potential. We tested whether integrating a group-based, early childhood parenting program into government healthcare clinics improve... We conducted a cluster-randomized controlled trial in 40 community clinics in the Kishorganj district of Bangladesh. We randomly assigned clinics (1:1) to deliver a group-based parenting interventions... 91% of children were tested at endline (396 intervention, 319 control). Multilevel analyses showed significant benefits of intervention to child cognition (effect size 0.85 SDs, 95% CI: 0.59, 1.11), l... A scalable parenting intervention, integrated into existing government health services and implemented by government health staff, led to significant benefits to child development and behavior....

Study protocol for 'the effects of multimodal training of cognitive and/or physical functions on cognition and physical fitness of older adults: a cluster randomized controlled trial'.

The elderly population worldwide is increasing exponentially which will be associated with more people suffering from cognition and fitness declines. The well-established benefits of exercise training... This study is a cluster randomized controlled trial (CRCT). A total of 285 older adults (age ≥ 60) from twenty elderly centres as clusters will be randomly selected and assigned to intervention groups... This study will provide substantial evidence that the integrated format of cognitive and physical exercises training will have higher cognition and fitness impact than the single training modes, and a... The trial has been registered in the ClinicalTrials.gov in U.S. NIH (ID: NCT04727450 , date: January 27, 2021)....

Effectiveness of a preschool asthma education programme, compared to usual care, on the frequency of acute asthma events: a community-based cluster randomised trial.

To determine whether an asthma intervention delivered within preschools can improve asthma outcomes in children aged 2-5 years with asthma or a high probability of asthma.... Between 2011 and 2013, we undertook a pragmatic, single-blind, cluster randomised trial in Auckland, New Zealand. We randomly assigned (1:1 ratio) preschools, and their children aged 2-5 years with as... We randomised 171 preschools, 85 to the intervention (341 children) and 86 to the control (334 children). We found no difference in the primary outcome (intervention: 216/341, 63% vs control: 181/334,... Combining asthma education with a nurse-led, evidence-based asthma assessment and education intervention led to sustained improvements in asthma control in this preschool population, but its effect on...

Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial.

To estimate the cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in a low endem... The study was part of a 2×2 factorial design cluster randomised controlled trial within the catchment area of 11 primary health facilities in Zambezi, Namibia.... Cost and outcome data were collected from the trial, which included 8948 community members that received interventions due to their residence within 500 m of malaria index cases.... The primary outcome was incremental cost effectiveness ratio (ICER) per in incident case averted. ICER per prevalent case and per disability-adjusted life years (DALY) averted were secondary outcomes,... rfMDA cost 1.1× more than RACD, and RAVC cost 1.7× more than no RAVC. Relative to RACD only, the cost of rfMDA+RAVC was double ($3082 vs $1553 per event). The ICERs for rfMDA versus RACD, RAVC versus ... Implemented alone or in combination, rfMDA and RAVC were cost effective in reducing malaria incidence and prevalence despite higher implementation costs in the intervention compared with control arms.... NCT02610400; Post-results....

Remote monitoring of rheumatoid arthritis (REMORA): study protocol for a stepped wedge cluster randomized trial and process evaluation of an integrated symptom tracking intervention.

Management of rheumatoid arthritis (RA) relies on symptoms reported by patients during infrequent outpatient clinic visits. These reports are often incomplete and inaccurate due to poor recall, leadin... In this superiority stepped wedge cluster-randomized controlled trial with continuous recruitment short exposure design, 16 rheumatology outpatient departments (clusters) recruit a total of 732 people... Our trial will generate high-quality evidence of comparative and cost-effectiveness of integrated symptom tracking compared to standard of care in people with RA, with our process evaluation deliverin... Registered 4-Jun-2024 on https://www.isrctn.com/ , ISRCTN51539448. TRIAL OPEN SCIENCE FRAMEWORK REPOSITORY: https://osf.io/sj9ha/ ....

Growth, physical, and cognitive function in children who are born HIV-free: School-age follow-up of a cluster-randomised trial in rural Zimbabwe.

Globally, over 16 million children were exposed to HIV during pregnancy but remain HIV-free at birth and throughout childhood by 2022. Children born HIV-free (CBHF) have higher morbidity and mortality... The SHINE trial enrolled pregnant women between 2012 and 2015 across 2 rural Zimbabwean districts. Co-primary outcomes were height-for-age Z-score and haemoglobin at age 18 months (clinicaltrials.gov ... In this study, we found that CBHF had reductions in cognitive function compared to CHU at 7 years of age across multiple domains. Further research is needed to define the biological and psychosocial m... ClinicalTrials.gov The SHINE follow-up study was registered with the Pan-African Clinical Trials Registry (PACTR202201828512110). The original SHINE trial was registered at NCT https://clinicaltrials....